PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY MARKET

INTRODUCTIONPERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY MARKET

A bile duct x-ray is called a percutaneous transhepatic cholangiogram (PTC). These are the tubes that bile travels through to reach the gallbladder and small intestine from the liver.

An interventional radiologist conducts the test in a radiology department.

The medical professional will utilise ultrasound and X-rays to find your liver and bile ducts. The liver is then accessed through the skin with a lengthy, thin, flexible needle.

The healthcare professional injects a dye known as contrast medium into the bile ducts. Contrast makes some areas stand out so they can be viewed. As the dye travels through the bile ducts and into the small intestine, more x-rays are taken. The nearest video monitor shows this.

A process to image the common and hepatic bile ducts. The liver or bile ducts are given an injection of a contrast material through the skin, and the ducts are x-rayed to locate the obstruction. also known as PTC.

A radiographic procedure called percutaneous transhepatic cholangiography, also known as a percutaneous hepatic cholangiogram (PTHC), is used to see the biliary tract's anatomy. After injecting a contrast agent into a bile duct in the liver, X-rays are taken. 

PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY MARKETSIZE AND FORECAST

 The Global Percutaneous Transhepatic Cholangiography market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY MARKETRECENT DEVELOPMENT

The radiologist will put a tiny needle through the skin and liver and into one of the bile ducts with the use of ultrasonography and live X-ray (fluoroscopy). The radiologist will next inject X-ray dye into the ducts and collect X-ray photographs. During this procedure, your child will be shielded by an X-ray shield.

Compared to PTBD, EUS-BD is associated with a greater rate of effective BD and a more controllable procedure-related adverse event profile. These data show the evidence for EUS-BD implementation success.

PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY MARKET COMPANY PROFILE

• Medscape
• B. Braun Melsungen AG
• KARL STORZ
• Cardinal Health
• GE Healthcare

THISPERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY MARKETREPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Percutaneous Transhepatic Cholangiography are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Percutaneous Transhepatic Cholangiography and key vendor selection criteria
3. Where is the Percutaneous Transhepatic Cholangiography manufactured? What is the average margin per unit?
4. Market share of Global Percutaneous Transhepatic Cholangiography market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Percutaneous Transhepatic Cholangiography in-house
6. key predictions for next 5 years in Global Percutaneous Transhepatic Cholangiography market
7. Average B-2-B Percutaneous Transhepatic Cholangiography market price in all segments
8. Latest trends in Percutaneous Transhepatic Cholangiography market, by every market segment
9. The market size (both volume and value) of the Percutaneous Transhepatic Cholangiography market in 2024-2030 and every year in between?
10. Production breakup of Percutaneous Transhepatic Cholangiography market, by suppliers and their OEM relationship